E. Keck

675 total citations
46 papers, 477 citations indexed

About

E. Keck is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, E. Keck has authored 46 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in E. Keck's work include Bone health and treatments (9 papers), Vitamin D Research Studies (8 papers) and Parathyroid Disorders and Treatments (6 papers). E. Keck is often cited by papers focused on Bone health and treatments (9 papers), Vitamin D Research Studies (8 papers) and Parathyroid Disorders and Treatments (6 papers). E. Keck collaborates with scholars based in Germany, United States and Switzerland. E. Keck's co-authors include H. Franck, F. van Valen, H. Worth, H. U. Schweikert, H. Schäfer, N. Niederle, F. Krück, H. Jürgens, H. L. Krüskemper and R. D. Hesch and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Respiratory and Critical Care Medicine and Biochemical and Biophysical Research Communications.

In The Last Decade

E. Keck

43 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Keck Germany	12	153	132	111	107	81	46	477
J.-M. Garel France	14	156 1.0×	47 0.4×	68 0.6×	132 1.2×	73 0.9×	41	615
K. Henze United States	8	222 1.5×	54 0.4×	97 0.9×	146 1.4×	36 0.4×	13	657
P.F. Hirsch United States	11	134 0.9×	54 0.4×	61 0.5×	89 0.8×	56 0.7×	16	478
Anthony D. Care United Kingdom	7	233 1.5×	28 0.2×	129 1.2×	90 0.8×	96 1.2×	10	580
Fischer Ja Switzerland	17	340 2.2×	66 0.5×	122 1.1×	131 1.2×	124 1.5×	50	803
Artemis Doulgeraki Greece	12	145 0.9×	84 0.6×	70 0.6×	50 0.5×	89 1.1×	33	358
Mattias Lindberg Sweden	5	254 1.7×	129 1.0×	135 1.2×	125 1.2×	348 4.3×	6	579
Simona Mencej-Bedrač Slovenia	7	213 1.4×	101 0.8×	96 0.9×	46 0.4×	150 1.9×	11	455
Mihali Raval-Pandya United States	6	192 1.3×	57 0.4×	40 0.4×	107 1.0×	134 1.7×	7	570
Scott Munson United States	14	187 1.2×	49 0.4×	39 0.4×	73 0.7×	49 0.6×	23	425

Countries citing papers authored by E. Keck

Since Specialization

Citations

This map shows the geographic impact of E. Keck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Keck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Keck more than expected).

Fields of papers citing papers by E. Keck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Keck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Keck. The network helps show where E. Keck may publish in the future.

Co-authorship network of co-authors of E. Keck

This figure shows the co-authorship network connecting the top 25 collaborators of E. Keck. A scholar is included among the top collaborators of E. Keck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Keck. E. Keck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goretzki, Peter E., et al.. (2009). cAMP-synthesis in a medullary thyroid carcinoma cell line: Response to adrenergic agents and Prostaglandines. Experimental and Clinical Endocrinology & Diabetes. 107(8). 488–495. 1 indexed citations

Franck, H., et al.. (2009). Serum 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin in Chronic Renal Failure. Experimental and Clinical Endocrinology & Diabetes. 91(2). 202–206.

Keck, E.. (2003). Therapie der postmenopausalen Osteoporose. Der Orthopäde. 32(12). 1104–1109. 2 indexed citations

Worth, H., et al.. (1994). Therapy of Steroid-Induced Bone Loss in Adult Asthmatics with Calcium, Vitamin D, and a Diphosphonate. American Journal of Respiratory and Critical Care Medicine. 150(2). 394–397. 44 indexed citations

Biro, George P., et al.. (1990). Die Hypomagnesiaemie-bedingte Hypocalciaemie: Funktioneller Hypoparathyreoidismus, Parathormon- und Vitamin D-Resistenz. Journal of Molecular Medicine. 68(13). 678–684. 3 indexed citations

Valen, F. van, H. Jürgens, W. Winkelmann, & E. Keck. (1989). Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68. Cellular Signalling. 1(5). 435–446. 6 indexed citations

Valen, F. van, E. Keck, & H. Jürgens. (1989). Functional characteristics of calcitonin gene‐related peptide receptors in human Ewing's sarcoma WE‐68 cells. FEBS Letters. 256(1-2). 170–174. 7 indexed citations

Valen, F. van, E. Keck, & H. Jürgens. (1989). Neuropeptide Y inhibits vasoactive intestinal peptide‐ and dopamine‐induced cyclic AMP formation in human Ewing's sarcoma WE‐68 cells. FEBS Letters. 249(2). 271–274. 13 indexed citations

Valen, F. van & E. Keck. (1988). Induction of glycogenolysis in cultured Ewing's sarcoma cells by dopamine and β-adrenergic agonists. Journal of Cancer Research and Clinical Oncology. 114(3). 266–272. 10 indexed citations

10.

Hesch, R. D., G. Delling, E. Keck, et al.. (1988). Results of a stimulatory therapy of low bone metabolism in osteoporosis with (1–38)hPTH and diphosphonate EHDP. Journal of Molecular Medicine. 66(19). 976–984. 31 indexed citations

11.

Drewe, Jürgen, Peter Dietsch, & E. Keck. (1988). Effect of vitamin D status on the activity of carbonic anhydrase in chicken epiphysis and kidney. Calcified Tissue International. 43(1). 26–32. 9 indexed citations

12.

Valen, F. van, Reinhard Prior, W. Wechsler, et al.. (1988). Immunzytochemische und biochemische Untersuchungen an einer Ewing-Sarkom-Zellinie: Hinweise für eine neurale in-vitro Differenzierung*. Klinische Pädiatrie. 200(3). 267–270. 6 indexed citations

13.

Valen, F. van & E. Keck. (1988). Forskolin inhibition of glucose transport in bone cell cultures through a cAMP-independent mechanism. Bone. 9(2). 89–92. 11 indexed citations

14.

Heuck, F. & E. Keck. (1988). Fortschritte der Osteologie in Diagnostik und Therapie. 4 indexed citations

15.

Valen, F. van & E. Keck. (1987). Gold(III) inhibits activated human osteosarcoma adenylate cyclase by an action at or near the catalytic component. Biochemical and Biophysical Research Communications. 144(3). 1109–1115. 1 indexed citations

16.

Lilienfeld-Toal, H. v., et al.. (1982). Immunoreactive Parathyroid Hormone in Early and Advanced Renal Failure. The Nephron journals/Nephron journals. 31(2). 116–122. 7 indexed citations

17.

Keck, E., et al.. (1978). [Symmetric cerebral calcification associated with disturbed parathyroid function (author's transl)].. PubMed. 73(43). 1507–12. 2 indexed citations

18.

Swift, R. W., Katherine H. Fisher, E.W. Hartsook, et al.. (1959). The Utilization of Dietary Protein and Energy as Affected by Fat and Carbohydrate. Journal of Nutrition. 68(2). 281–288. 12 indexed citations

19.

Swift, R. W., Katherine H. Fisher, C. E. French, et al.. (1958). The Effect of High Versus Low Protein Equicaloric Diets on the Heat Production of Human Subjects. Journal of Nutrition. 65(1). 89–102. 15 indexed citations

20.

Swift, R. W., Katherine H. Fisher, J. W. Bratzler, et al.. (1957). Relative dynamic effects of high versus low protein diets of equicaloric content.. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact